US Stock MarketDetailed Quotes

BriaCell Therapeutics (BCTX)

Watchlist
  • 3.880
  • +0.150+4.02%
Close Apr 24 16:00 ET
  • 3.953
  • +0.073+1.89%
Post 20:01 ET
28.13MMarket Cap-0.27P/E (TTM)

BriaCell Therapeutics (BCTX) Income Statement

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q2)Jan 31, 2026
(Q1)Oct 31, 2025
(FY)Jul 31, 2025
(Q4)Jul 31, 2025
(Q3)Apr 30, 2025
(Q2)Jan 31, 2025
(Q1)Oct 31, 2024
(FY)Jul 31, 2024
(Q4)Jul 31, 2024
(Q3)Apr 30, 2024
Total revenue
0
0
0
0
0
0
0
0
0
0
Operating revenue
--0
--0
--0
--0
--0
--0
--0
--0
--0
--0
Cost of revenue
Gross profit
Operating expense
5.05%7.53M
61.52%8.32M
-18.38%27.2M
48.31%8.55M
-31.44%6.33M
-27.06%7.17M
-39.40%5.15M
43.22%33.33M
-25.15%5.77M
62.58%9.23M
Selling and administrative expenses
-0.48%1.48M
10.21%1.64M
-3.55%5.93M
5.98%1.44M
-3.43%1.52M
-5.56%1.48M
-9.62%1.49M
-22.47%6.15M
-46.32%1.36M
-13.46%1.57M
-General and administrative expense
-0.48%1.48M
10.21%1.64M
-3.55%5.93M
5.98%1.44M
-3.43%1.52M
-5.56%1.48M
-9.62%1.49M
-22.47%6.15M
-46.32%1.36M
-13.46%1.57M
Research and development costs
6.49%6.05M
82.35%6.68M
-21.74%21.27M
61.40%7.11M
-37.18%4.81M
-31.16%5.68M
-46.55%3.67M
77.21%27.18M
-14.75%4.41M
98.36%7.66M
Operating profit
-5.05%-7.53M
-61.52%-8.32M
18.38%-27.2M
-48.31%-8.55M
31.44%-6.33M
27.06%-7.17M
39.40%-5.15M
-43.22%-33.33M
25.15%-5.77M
-62.58%-9.23M
Net non-operating interest income expense
125.57%105.64K
271.51%48.48K
-71.19%82.98K
1,672,100.00%33.44K
-166.30%-10.35K
-42.60%46.83K
-93.16%13.05K
-67.68%288.02K
-100.00%2
-93.84%15.61K
Non-operating interest income
125.57%105.64K
271.51%48.48K
-58.35%119.96K
1,672,100.00%33.44K
70.65%26.63K
-42.60%46.83K
-93.16%13.05K
-67.68%288.02K
-100.00%2
-93.84%15.61K
Non-operating interest expense
----
----
--36.98K
--0
--36.98K
----
----
--0
--0
--0
Other net income (expense)
-83.60%128.74K
99.44%-3.87K
-97.99%565.68K
-92.11%356.72K
-98.96%113.67K
149.48%784.78K
-104.83%-689.49K
1,252.34%28.11M
-11.01%4.52M
1,965.18%10.91M
Gain on sale of security
-76.95%190.73K
106.63%40.96K
-97.20%789.9K
-91.16%404.1K
-98.39%176.41K
152.78%827.37K
-104.33%-617.98K
1,257.46%28.22M
-10.00%4.57M
1,972.18%10.94M
Earnings from equity interest
-45.58%-61.99K
37.31%-44.83K
-110.51%-224.21K
7.41%-47.38K
-69.58%-62.74K
-132.13%-42.58K
---71.52K
---106.51K
---51.17K
---37K
Income before tax
-15.13%-7.3M
-42.01%-8.28M
-438.50%-26.56M
-553.78%-8.16M
-467.85%-6.22M
44.08%-6.34M
-197.83%-5.83M
75.71%-4.93M
48.37%-1.25M
134.57%1.69M
Income tax
Net income
-15.13%-7.3M
-42.01%-8.28M
-438.50%-26.56M
-553.78%-8.16M
-467.85%-6.22M
44.08%-6.34M
-197.83%-5.83M
75.71%-4.93M
48.37%-1.25M
134.57%1.69M
Net income continuous Operations
-15.13%-7.3M
-42.01%-8.28M
-438.50%-26.56M
-553.78%-8.16M
-467.85%-6.22M
44.08%-6.34M
-197.83%-5.83M
75.71%-4.93M
48.37%-1.25M
134.57%1.69M
Minority interest income
-61.77%-75.07K
-198.01%-80.76K
-74.38%-244.27K
-110.30%-72.74K
-316.83%-98.03K
-18.07%-46.41K
36.49%-27.1K
-140.08K
-34.59K
-23.52K
Net income attributable to the parent company
-14.79%-7.22M
-41.28%-8.2M
-449.14%-26.31M
-566.41%-8.09M
-457.10%-6.13M
44.30%-6.29M
-196.68%-5.8M
76.40%-4.79M
49.80%-1.21M
135.05%1.72M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders
-14.79%-7.22M
-41.28%-8.2M
-449.14%-26.31M
-566.41%-8.09M
-457.10%-6.13M
44.30%-6.29M
-196.68%-5.8M
76.40%-4.79M
49.80%-1.21M
135.05%1.72M
Basic earnings per share
88.93%-2.58
86.69%-4.35
-42.38%-62.19
57.39%-4.295
-201.86%-16.4
78.09%-23.31
-157.32%-32.67
77.60%-43.68
55.20%-10.08
133.54%16.1
Diluted earnings per share
88.93%-2.58
86.69%-4.35
-42.38%-62.19
57.39%-4.295
-201.86%-16.4
78.09%-23.31
56.44%-32.67
77.60%-43.68
55.20%-10.08
133.54%16.1
Dividend per share
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
--
Unqualified Opinion with Explanatory Notes
--
--
--
--
Unqualified Opinion with Explanatory Notes
--
--
(Q2)Jan 31, 2026(Q1)Oct 31, 2025(FY)Jul 31, 2025(Q4)Jul 31, 2025(Q3)Apr 30, 2025(Q2)Jan 31, 2025(Q1)Oct 31, 2024(FY)Jul 31, 2024(Q4)Jul 31, 2024(Q3)Apr 30, 2024
Total revenue 0000000000
Operating revenue --0--0--0--0--0--0--0--0--0--0
Cost of revenue
Gross profit
Operating expense 5.05%7.53M61.52%8.32M-18.38%27.2M48.31%8.55M-31.44%6.33M-27.06%7.17M-39.40%5.15M43.22%33.33M-25.15%5.77M62.58%9.23M
Selling and administrative expenses -0.48%1.48M10.21%1.64M-3.55%5.93M5.98%1.44M-3.43%1.52M-5.56%1.48M-9.62%1.49M-22.47%6.15M-46.32%1.36M-13.46%1.57M
-General and administrative expense -0.48%1.48M10.21%1.64M-3.55%5.93M5.98%1.44M-3.43%1.52M-5.56%1.48M-9.62%1.49M-22.47%6.15M-46.32%1.36M-13.46%1.57M
Research and development costs 6.49%6.05M82.35%6.68M-21.74%21.27M61.40%7.11M-37.18%4.81M-31.16%5.68M-46.55%3.67M77.21%27.18M-14.75%4.41M98.36%7.66M
Operating profit -5.05%-7.53M-61.52%-8.32M18.38%-27.2M-48.31%-8.55M31.44%-6.33M27.06%-7.17M39.40%-5.15M-43.22%-33.33M25.15%-5.77M-62.58%-9.23M
Net non-operating interest income expense 125.57%105.64K271.51%48.48K-71.19%82.98K1,672,100.00%33.44K-166.30%-10.35K-42.60%46.83K-93.16%13.05K-67.68%288.02K-100.00%2-93.84%15.61K
Non-operating interest income 125.57%105.64K271.51%48.48K-58.35%119.96K1,672,100.00%33.44K70.65%26.63K-42.60%46.83K-93.16%13.05K-67.68%288.02K-100.00%2-93.84%15.61K
Non-operating interest expense ----------36.98K--0--36.98K----------0--0--0
Other net income (expense) -83.60%128.74K99.44%-3.87K-97.99%565.68K-92.11%356.72K-98.96%113.67K149.48%784.78K-104.83%-689.49K1,252.34%28.11M-11.01%4.52M1,965.18%10.91M
Gain on sale of security -76.95%190.73K106.63%40.96K-97.20%789.9K-91.16%404.1K-98.39%176.41K152.78%827.37K-104.33%-617.98K1,257.46%28.22M-10.00%4.57M1,972.18%10.94M
Earnings from equity interest -45.58%-61.99K37.31%-44.83K-110.51%-224.21K7.41%-47.38K-69.58%-62.74K-132.13%-42.58K---71.52K---106.51K---51.17K---37K
Income before tax -15.13%-7.3M-42.01%-8.28M-438.50%-26.56M-553.78%-8.16M-467.85%-6.22M44.08%-6.34M-197.83%-5.83M75.71%-4.93M48.37%-1.25M134.57%1.69M
Income tax
Net income -15.13%-7.3M-42.01%-8.28M-438.50%-26.56M-553.78%-8.16M-467.85%-6.22M44.08%-6.34M-197.83%-5.83M75.71%-4.93M48.37%-1.25M134.57%1.69M
Net income continuous Operations -15.13%-7.3M-42.01%-8.28M-438.50%-26.56M-553.78%-8.16M-467.85%-6.22M44.08%-6.34M-197.83%-5.83M75.71%-4.93M48.37%-1.25M134.57%1.69M
Minority interest income -61.77%-75.07K-198.01%-80.76K-74.38%-244.27K-110.30%-72.74K-316.83%-98.03K-18.07%-46.41K36.49%-27.1K-140.08K-34.59K-23.52K
Net income attributable to the parent company -14.79%-7.22M-41.28%-8.2M-449.14%-26.31M-566.41%-8.09M-457.10%-6.13M44.30%-6.29M-196.68%-5.8M76.40%-4.79M49.80%-1.21M135.05%1.72M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders -14.79%-7.22M-41.28%-8.2M-449.14%-26.31M-566.41%-8.09M-457.10%-6.13M44.30%-6.29M-196.68%-5.8M76.40%-4.79M49.80%-1.21M135.05%1.72M
Basic earnings per share 88.93%-2.5886.69%-4.35-42.38%-62.1957.39%-4.295-201.86%-16.478.09%-23.31-157.32%-32.6777.60%-43.6855.20%-10.08133.54%16.1
Diluted earnings per share 88.93%-2.5886.69%-4.35-42.38%-62.1957.39%-4.295-201.86%-16.478.09%-23.3156.44%-32.6777.60%-43.6855.20%-10.08133.54%16.1
Dividend per share
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions ----Unqualified Opinion with Explanatory Notes--------Unqualified Opinion with Explanatory Notes----
Market Insights
China Concept Stocks
View More
Middle East conflict spreads to the stock market! How should investors respond?
According to Lebanese media reports, in the early hours of the 27th local time, Iran conveyed a three-phase negotiation plan to the US throu Show More